Insight Molecular Diagnostics Inc. (IMDX) Gross Margin
- Gross margin · 12 months: Value 48.32%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 48.32% | Gross profit / revenue. Period ending 2026-06-30. $807.00K ÷ $1.67M × 100 ≈ 48.32% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 807.00K USD | Gross Profit |
| Revenue | 1.67M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $807.00K | $1.67M | (m) | 48.32% |
| 2026-03-31 | $988.00K | $1.95M | (m) | 50.69% |
| 2025-12-31 | $2.30M | $4.05M | (m) | 56.67% |
| 2025-09-30 | $2.40M | $4.40M | (m) | 54.45% |
| 2025-06-30 | $2.32M | $4.26M | (m) | 54.50% |
| 2025-03-31 | $2.02M | $3.84M | (m) | 52.56% |
| 2024-12-31 | $740.00K | $1.88M | (m) | 39.34% |
| 2024-09-30 | $28.00K | $709.00K | (m) | 3.95% |
| 2024-06-30 | $226.00K | $1.02M | (m) | 22.09% |
| 2024-03-31 | $305.00K | $1.38M | (m) | 22.07% |
| 2023-12-31 | $413.00K | $1.50M | (m) | 27.48% |
| 2023-09-30 | $503.00K | $1.46M | (m) | 34.38% |
| 2023-06-30 | $-14.00K | $1.10M | (m) | -1.27% |
| 2023-03-31 | $-255.00K | $875.00K | (m) | -29.14% |
| 2022-12-31 | $-18.00K | $958.00K | (m) | -1.88% |
| 2022-09-30 | $-652.00K | $8.10M | (m) | -8.05% |
| 2022-06-30 | $-344.00K | $8.06M | (m) | -4.27% |
| 2022-03-31 | $-424.00K | $8.03M | (m) | -5.28% |
| 2021-12-31 | $188.00K | $7.73M | (m) | 2.43% |
| 2021-09-30 | (m) | $4.64M | (m) | (m) |
| 2021-06-30 | (m) | $4.21M | (m) | (m) |
| 2021-03-31 | (m) | $2.32M | (m) | (m) |
| 2020-12-31 | (m) | $1.22M | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $0.00 | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |